The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents
Andreas M ReimoldDallas Veterans Affairs Medical Center and Rheumatic Diseases Division, University of Texas Southwestern Medical Center, Dallas, TX, USAAbstract: Adalimumab (ADA) is a biologic medication that dampens inflammatory pathways by binding to the cytokine tumor necrosis factor alpha. The...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cfc3051d236445f0af47fea6195a5b7a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|